Cumberland Pharmaceuticals Inc.
CPIX
$2.28
$0.125.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 69.38% | 71.75% | 61.08% | -3.19% | -348.15% |
| Total Depreciation and Amortization | 2.14% | 1.98% | 2.52% | 4.73% | 14.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -109.81% | -144.92% | -127.30% | -174.65% | 192.62% |
| Change in Net Operating Assets | 161.45% | 165.40% | -9.39% | -72.10% | -78.87% |
| Cash from Operations | 562.80% | 1,095.17% | 0.88% | -110.05% | -116.99% |
| Capital Expenditure | 11.25% | 39.04% | 66.37% | 76.36% | -42.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -440.47% | -425.62% | -559.64% | -29.21% | 149.36% |
| Cash from Investing | -580.85% | -1,388.43% | -10,692.38% | 154.63% | 134.27% |
| Total Debt Issued | -86.48% | -56.00% | -20.26% | 22.28% | 35.74% |
| Total Debt Repaid | 56.42% | 20.83% | -11.23% | -3.17% | -7.97% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 45.95% | 41.71% | 27.94% | 21.82% | 9.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 37.96% | 35.88% | 34.42% | 47.49% | 24.67% |
| Cash from Financing | -8,537.87% | -2,847.24% | -140.44% | 102.65% | 101.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.43% | -36.90% | -259.09% | 75.12% | -0.92% |